Subscribe to RSS
DOI: 10.1055/s-0030-1255106
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
Multifactorial Genesis of Pancreatitis in Primary Hyperparathyroidism: Evidence for “Protective” (PRSS2) and “Destructive” (CTRC) Genetic Factors
Publication History
received 26.01.2010
first decision 05.05.2010
accepted 02.06.2010
Publication Date:
12 July 2010 (online)

Abstract
Objective: A relationship between primary hyperparathyroidism (pHPT) and pancreatitis has long been debated and remains a rare epiphenomenon. In a cohort of patients with pHPT and pancreatitis mutations in the serine protease inhibitor Kazal type I (SPINK1) and cystic fibrosis transmembrane conductance regulator (CFTR) genes, that increase the risk for pancreatitis have already been detected. Among the identification of additional pancreatitis-associtated mutations in the Chymotrypsin C gene (CTRC) it became clear that also protective genetic variants exist in the anionic trypsinogen gene (PRSS2) that decrease susceptibility for pancreatitis. Our aim was to detect either protective or inducing genetic factors in a large cohort of pHPT patients.
Methods: Among 1 259 patients with pHPT, 57 patients were identified with pancreatitis (4.5%). DNA was available from 31 patients (16 acute pancreatitis/15 chronic pancreatitis). These individuals and 100 patients with pHPT without pancreatitis were analysed for CTRC (p.R254W and p.K247_R254del) and PRSS2 (p.G191R) mutations using melting curve analysis and DNA sequencing or PCR and gel electrophoresis (in case of p.K247_R254del CTRC).
Results: 2 of 31 patients with pHPT and pancreatitis carried the CTRC p.R254W missense mutation (6.5%), while all 100 pHPT controls without pancreatitis showed no CTRC mutation (P=0.055). No further SPINK1 p.N34S (n=4) mutations were detected but the probability of either CTRC or SPINK1 mutations in pHPT patients with pancreatitis is high (P<0.05). 1 patient was trans-heterozygous (SPINK1: N34S/CTRC p.R254W). CTRC p.K247_R254del was not detected in both groups. PRSS2 (p.G191R) mutation was present in 1 patient with pancreatitis (3.2%) and in 6 pHPT controls (6%) (P=1).
Conclusion: This study underlines the relevance of a genetic background in pHPT related pancreatitis. However, it only indicates that the CTRC (p.R254W) mutation might also contribute to the panel of mutations (SPINK1 and CFTR) that have been formerly reported to elevate pancreatitis susceptibility in pHPT. Besides it suggests that protective genetic variants, i. e., p.G191R PRSS2, may contribute to the low prevalence of pancreatitis in pHPT patients.
Key words
pancreatitis - hyperparathyroidism - hypercalcaemia - PRSS2 - CTRC
References
- 1
Felderbauer P, Karakas E, Fendrich V. et al .
Pancreatitis risk in primary hyperparathyroidism: Relation to mutations in the spink1
trypsin inhibitor (N34S) and the cystic fibrosis gene.
Am J Gastroenterol.
2008;
103
368-374
MissingFormLabel
- 2
Sutton R, Criddle D, Raraty MG. et al .
Signal transduction, calcium and acute pancreatitis.
Pancreatology.
2003;
3
497-505
MissingFormLabel
- 3
Felderbauer P, Karakas E, Fendrich V. et al .
Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated
with mutations in the casr gene.
Exp Clin Endocrinol Diabetes.
2007;
115
527-529
MissingFormLabel
- 4
Rosendahl J, Witt H, Szmola R. et al .
Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated
with chronic pancreatitis.
Nat Genet.
2008;
40
78-82
MissingFormLabel
- 5
Rinderknecht H, Adham NF, Renner IG. et al .
A possible zymogen self-destruct mechanism preventing pancreatic autodigestion.
Int J Pancreatol.
1988;
3
33-44
MissingFormLabel
- 6
Szmola R, Sahin-Toth M.
Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity
with rinderknecht's enzyme y.
Proc Natl Acad Sci USA.
2007;
104
11227-11232
MissingFormLabel
- 7
Tomomura A, Yamada H, Fujimoto K. et al .
Determination of amino acid sequence responsible for suppression of bone resorption
by serum calcium-decreasing factor (caldecrin).
FEBS Lett.
2001;
508
454-458
MissingFormLabel
- 8
Tomomura A, Fukushige T, Noda T. et al .
Serum calcium-decreasing factor (caldecrin) from porcine pancreas has proteolytic
activity which has no clear connection with the calcium decrease.
FEBS Lett.
1992;
301
277-281
MissingFormLabel
- 9
Tomomura A, Fukushige T, Tomomura M. et al .
Caldecrin proform requires trypsin activation for the acquisition of serum calcium-decreasing
activity.
FEBS Lett.
1993;
335
213-216
MissingFormLabel
- 10
Witt H, Sahin-Toth M, Landt O. et al .
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic
pancreatitis.
Nat Genet.
2006;
38
668-673
MissingFormLabel
- 11
Etemad B, Whitcomb DC.
Chronic pancreatitis: Diagnosis, classification, and new genetic developments.
Gastroenterology.
2001;
120
682-707
MissingFormLabel
- 12
Sahin-Toth M.
Biochemical models of hereditary pancreatitis.
Endocrinol Metab Clin North Am.
2006;
35
303-312
ix
MissingFormLabel
- 13
Bess MA, Edis AJ, van Heerden JA.
Hyperparathyroidism and pancreatitis. Chance or a causal association?.
JAMA.
1980;
243
246-247
MissingFormLabel
- 14
van Lanschot JJ, Bruining HA.
Primary hyperparathyroidism and pancreatitis.
Neth J Surg.
1984;
36
38-41
MissingFormLabel
- 15
Koppelberg T, Bartsch D, Printz H. et al .
[pancreatitis in primary hyperparathyroidism (phpt) is a complication of advanced
phpt].
Dtsch Med Wochenschr.
1994;
119
719-724
MissingFormLabel
- 16
Carnaille B, Oudar C, Pattou F. et al .
Pancreatitis and primary hyperparathyroidism: Forty cases.
Aust N Z J Surg.
1998;
68
117-119
MissingFormLabel
- 17
Agarwal A, George RK, Gupta SK. et al .
Pancreatitis in patients with primary hyperparathyroidism.
Indian J Gastroenterol.
2003;
22
224-225
MissingFormLabel
- 18
Sherwood MW, Prior IA, Voronina SG. et al .
Activation of trypsinogen in large endocytic vacuoles of pancreatic acinar cells.
Proc Natl Acad Sci USA.
2007;
104
5674-5679
MissingFormLabel
- 19
Santhosh S, Witt H, te Morsche RH. et al .
A loss of function polymorphism (G191R) of anionic trypsinogen (PRSS2) confers protection
against chronic pancreatitis.
Pancreas.
2008;
36
317-320
MissingFormLabel
Correspondence
P. FelderbauerMD
Department of Medicine I
St. Josef-Hospital
Ruhr-University of Bochum
Gudrunstraße 54
44791 Bochum
Germany
Phone: +49/0234/509 2378
Fax: +49/0234/509 2396
Email: peter.felderbauer@rub.de